Susquehanna International Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-88,896
| Closed | -$18K | – | 5479 |
|
|
2018
Q1 | $18K | Buy |
88,896
+36,800
| +71% | +$7.45K | ﹤0.01% | 3234 |
|
|
2017
Q4 | $67K | Buy |
52,096
+27,245
| +110% | +$35K | ﹤0.01% | 3395 |
|
|
2017
Q3 | $53K | Sell |
24,851
-11,235
| -31% | -$24K | ﹤0.01% | 2961 |
|
|
2017
Q2 | $105K | Sell |
36,086
-11,627
| -24% | -$33.8K | ﹤0.01% | 3239 |
|
|
2017
Q1 | $164K | Sell |
47,713
-102
| -0.2% | -$351 | ﹤0.01% | 2891 |
|
|
2016
Q4 | $83K | Buy |
47,815
+27,672
| +137% | +$48K | ﹤0.01% | 3922 |
|
|
2016
Q3 | $67K | Buy |
20,143
+8,680
| +76% | +$28.9K | ﹤0.01% | 2749 |
|
|
2016
Q2 | $49K | Sell |
11,463
-18,939
| -62% | -$81K | ﹤0.01% | 3008 |
|
|
2016
Q1 | $171K | Buy |
30,402
+7,935
| +35% | +$44.6K | ﹤0.01% | 3412 |
|
|
2015
Q4 | $386K | Sell |
22,467
-67,902
| -75% | -$1.17M | ﹤0.01% | 3205 |
|
|
2015
Q3 | $1.91M | Buy |
90,369
+41,734
| +86% | +$880K | ﹤0.01% | 1702 |
|
|
2015
Q2 | $2.41M | Sell |
48,635
-15,652
| -24% | -$775K | ﹤0.01% | 1649 |
|
|
2015
Q1 | $5.03M | Sell |
64,287
-40,292
| -39% | -$3.16M | ﹤0.01% | 853 |
|
|
2014
Q4 | $6.34M | Buy |
104,579
+21,165
| +25% | +$1.28M | ﹤0.01% | 825 |
|
|
2014
Q3 | $3.55M | Sell |
83,414
-32,436
| -28% | -$1.38M | ﹤0.01% | 1220 |
|
|
2014
Q2 | $7.16M | Buy |
115,850
+85,131
| +277% | +$5.26M | ﹤0.01% | 784 |
|
|
2014
Q1 | $2M | Sell |
30,719
-9,146
| -23% | -$594K | ﹤0.01% | 1555 |
|
|
2013
Q4 | $2.25M | Sell |
39,865
-2,785
| -7% | -$157K | ﹤0.01% | 1539 |
|
|
2013
Q3 | $2.62M | Buy |
42,650
+9,068
| +27% | +$557K | ﹤0.01% | 1289 |
|
|
2013
Q2 | $1.97M | Buy |
+33,582
| New | +$1.97M | ﹤0.01% | 1513 |
|